The Indianapolis based Eli Lilly is making a big, big change to lower the price of its new weight loss drug. So this morning, Lilly announced that it's releasing a new form of Zet bound at roughly half its usual monthly price. You can now get 2.5 mg, single dose vials for $399 a month. This is through Lily's direct to consumer website and you can get the 5 mg single dose vials for $549 a month. Plus, you won't need the auto injector pins for these vials. So this move really could be a game changer for people who have wanted to use these drugs. It's been denied by their insurance and so they simply just could not afford it. Our Emily Longnecker spoke with a woman who has not had to worry about the cost and now hopes that it will help more people like her. Never looking back. I wish I could take this forever. Six months ago, Mary Beetle was in a very different place than the one she is now. Beetle used to weigh 230 pounds. Now she's lost 50 of it because I feel so healthy. I don't hurt anymore. I'm not taking my cholesterol medicine. I'm not taking my thyroid pills anymore. Beetle credits Lily's drug Zep bound that her doctor prescribed to her for weight loss took that and I'm never looking back. Beetle thankful her insurance covers the drug. She only pays $25 a month for it compared to the $1000 paid out of pocket by people whose insurance doesn't cover it or for those who don't even have insurance. Now, the same drug that helped Beetle could be accessible to more consumers. Lily's releasing a new form of the drug right now. It comes in prefilled, injectable pens. The drug will also come in vials with a syringe lowering the cost to around $500 for a monthly supply if someone's insurance doesn't cover it. And again, as I said, the biggest limitation has been the cost. The doctor who treats beetles says more people are asking about Zep bound now that it'll be available at a lower cost at the price point that they are offering. Now, it becomes a lot more affordable for a lot more patients for those who don't have insurance like Mary Beetles does. The 53 year old is happy more people could still have access to Zet bound. She says the drug has given her a whole new life. I'm right after my grandson now. I mean, I'm just, I don't sleep a lot anymore in Indianapolis, Emily. Longnecker. 13 news. All right, thank you, Emily. And just last week, a new study revealed the drug and zep bound is preventing new cases of diabetes by 94%. The researchers found that trait can cut the risk of type two diabetes in pre diabetic adults who are overweight or obese after three years of weekly injection. Now, Lily's Chief Scientific Officer talked with 13 news and told us that this is the first time this study results that they've gotten evidence that they can slow the growth of type two diabetes. And now they're taking their data to the FDA and other regulators around the world.